Naramig, Filmtabletten

7680542720227 CH-54272 Filmtabletten
Naramig, Filmtabletten
Naramig, Filmtabletten
Naramig, Filmtabletten
1 / 3
google

Article details

Package size
12
Selling units
12
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
94.07 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 60.95
Specialties list
Yes
Generic
No
SL addition date: 15/03/1998

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
54272
Drug name
Naramig, Filmtabletten
Galenic form
TAB
ATC Code
N02CC02
Authorization status
Z
Dispensing category
B
First authorization
30/09/1997
Authorization expiration date
31/12/9999
IT Number
02.05.1.
Domain
Human medicine
Field of application
Akutbehandlung von Migräneanfällen mit oder ohne Aura

Package details

Description (FR)
NARAMIG cpr pell 2.5 mg 12 pce
Description (DE)
NARAMIG Filmtabl 2.5 mg 12 Stk
Market launch
30/09/1997
Narcotic (BTM)
No

Other package sizes (1)

NARAMIG cpr pell 2.5 mg 6 pce
6 TABL
GTIN: 7680542720142
View